Related Experiment Video
Updated: Jul 27, 2026
08:56
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Risk factors and prognosis in primary biliary cirrhosis
B M Goudie1, A D Burt, G J Macfarlane
1Department of Medicine, Western Infirmary, Glasgow, Scotland.
The American Journal of Gastroenterology
|July 1, 1989
Summary
This study identified key clinical and histologic factors impacting survival in primary biliary cirrhosis (PBC) patients. Ascites, bilirubin, variceal hemorrhage, age, fibrosis, bilirubinostasis, and Mallory's hyalin predict reduced survival in PBC.
Area of Science:
- Hepatology
- Internal Medicine
- Clinical Research
Background:
- Primary biliary cirrhosis (PBC) is a chronic liver disease with significant impact on patient survival.
- Understanding prognostic factors is crucial for managing PBC and improving patient outcomes.
Purpose of the Study:
- To investigate the relationship between various clinical and histologic variables and survival in patients with primary biliary cirrhosis.
- To identify independent risk factors that correlate with reduced survival in PBC.
Main Methods:
- A cohort of 195 patients diagnosed with primary biliary cirrhosis was followed for a mean of 6 years.
- Kaplan-Meier survival estimates were used to assess mortality.
- Statistical analysis identified independent clinical and histologic predictors of survival.
Main Results:
- The 5-year and 10-year mortality rates from liver disease were 40% and 60%, respectively.
- Independent clinical risk factors for reduced survival included ascites, elevated serum bilirubin, variceal hemorrhage, and patient age.
- Independent histologic risk factors identified were the extent of hepatic fibrosis, bilirubinostasis, and Mallory's hyalin.
Conclusions:
- Several clinical and histologic factors significantly influence survival in primary biliary cirrhosis.
- Identification of these prognostic markers can aid in clinical decision-making and patient management for PBC.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...